Sudarshan Sukhani, s2analytics.com advises to buy Aurobindo Pharma on every dips.
Sukhani told CNBC-TV18, “I am upbeat in Aurobindo Pharma. It had a sharp correction, some kind of a mini bear market in it, and then it bottomed out. There was a basing formation and I would be a buyer in Aurobindo Pharma. Every dip is a buying opportunity.”
Aurobindo Pharma touched its 52-week high Rs 204.90 and 52-week low Rs 104.50 on 07 January, 2013 and 10 August, 2012, respectively. Currently, it is trading 14.49 percent below its 52-week high and 67.66 percent above its 52-week low. Market capitalisation stands at Rs 5,102.02 crore.